Lung Diseases - HLBS-PopOmics -

Specific PHGKB|HLBS|PHGKB

Lung Diseases

- HLBS-PopOmics -

What's New

Last Posted: May 17, 2018

---

• A Next-Generation Sequencing Primer-How Does It Work and What Can It Do?  
  Alekseyev Yuriy O et al. Academic pathology 52374289518766521
• Clinical Genetics in Interstitial Lung Disease.  
  Newton Chad A et al. Frontiers in medicine 2018 5116
• Newborn Screening for Severe Combined Immunodeficiency.  
  Routes John et al. Current allergy and asthma reports 2018 May 18(6) 34
• Severe Combined Immunodeficiency: A Case Series and Review from a Tertiary Pediatric Hospital.  
  Fallah Shahrzad et al. Iranian journal of allergy, asthma, and immunology 2018 Apr 17(2) 201-207
• Application of Plasma Genotyping Technologies in Non-Small Cell Lung Cancer: A Practical Review.  
  Sacher Adrian G et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2017 Sep 12(9) 1344-1356
• Cystic Fibrosis Disease Modifiers: Complex Genetics Defines the Phenotypic Diversity in a Monogenic Disease.  
  O'Neal Wanda K et al. Annual review of genomics and human genetics 2018 Apr
• Evaluating the Impact of Precision Medicine: How Ivacaftor Reduces Hospitalizations of Patients with Cystic Fibrosis
  RF Green al, CDC Blog Post, May 8, 2018
• Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.  
  Fortin Patricia M et al. The Cochrane database of systematic reviews 2018 May 5CD012349
• Laboratory Testing for Activated Protein C Resistance (APCR).  
  Mohammed Soma et al. Methods in molecular biology (Clifton, N.J.) 2017 1646137-143
• Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.  
  Iwama E et al. Annals of oncology : official journal of the European Society for Medical Oncology 2017 28(1) 136-141
• Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.  
  Feng Lisa B et al. Health affairs (Project Hope) 2018 May 37(5) 773-779
• Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis–Related Hospitalizations  
  LB Feng et al, Health Affairs, May 2018
• Disease-modifying genetic factors in cystic fibrosis.  
  Marson Fernando A L et al. Current opinion in pulmonary medicine 2018 May (3) 296-308
• [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?]  
  Albin Nicolas et al. Bulletin du cancer 2018 Apr 105(4) 375-396
• Delays in adding new newborn screening tests harm babies, families  
  R Moy et al, STatNews, Apr 30, 2018